[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581462":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":11,"centralContacts":11,"locations":26,"responsibleParty":218,"collaborators":11,"id":220,"slug":221,"hasResults":222,"nctId":223,"briefTitle":224,"officialTitle":225,"acronym":226,"eligibilityCriteria":227,"healthyVolunteers":222,"sex":228,"minAge":229,"maxAge":11,"enrollmentInfo":230,"targetDuration":11,"studyType":233,"phases":234,"briefSummary":236,"conditions":237,"keywords":239,"overallStatus":29,"whyStopped":11,"lastUpdateSubmitDate":249,"lastUpdatePostDateStruct":250,"startDateStruct":253,"completionDateStruct":255,"leadSponsor":257,"locationsCount":258},{"fullName":5,"class":6},"EXACT Therapeutics AS","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Acoustic Cluster Therapy (ACT) with mFOLFIRINOX","EXPERIMENTAL",null,[13,14],"Combination Product: Acoustic Cluster Therapy","Drug: Modified FOLFIRINOX",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":11},"COMBINATION_PRODUCT","Acoustic Cluster Therapy","Drug: PS101; Device: Ultrasound",[9],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":11},"DRUG","Modified FOLFIRINOX","Chemotherapy",[9],[27,50,70,87,104,123,141,160,181,198],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"HonorHealth Research Institute","RECRUITING","Scottsdale","Arizona","85258","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-111.89903,33.50921,{"lat":39,"lon":38},[42,47],{"name":43,"role":44,"phone":45,"phoneExt":11,"email":46},"Lu Study Coordinator","CONTACT","(+1) (480) 323 1364","clinicaltrials@honorhealth.com, lzhao@honorhealth.com",{"name":48,"role":49,"phone":11,"phoneExt":11,"email":11},"Erkut Borazanci, MD","PRINCIPAL_INVESTIGATOR",{"facility":51,"status":29,"city":52,"state":53,"zip":54,"country":33,"countryCode":34,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Stanford Cancer Center Palo Alto","Stanford","California","94305",{"type":36,"coordinates":56},[57,58],-122.16608,37.42411,{"lat":58,"lon":57},[61,65,68],{"name":62,"role":44,"phone":63,"phoneExt":11,"email":64},"Britney Williams","650-736-3688","bw718@stanford.edu",{"name":66,"role":44,"phone":11,"phoneExt":11,"email":67},"Isabel Leonio ( Study Coordinator)","ileonio@stanford.edu",{"name":69,"role":49,"phone":11,"phoneExt":11,"email":11},"Pejman Ghanouni, MD:PhD",{"facility":71,"status":29,"city":72,"state":73,"zip":74,"country":33,"countryCode":34,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"Beth Israel Deaconess Medical Center - Division of Hematology\u002FOncology","Boston","Massachusetts","02215",{"type":36,"coordinates":76},[77,78],-71.05977,42.35843,{"lat":78,"lon":77},[81,85],{"name":82,"role":44,"phone":83,"phoneExt":11,"email":84},"Selma Sinanovic Study Coordinator","+1 617-975-7411","ssinanov@bidmc.harvard.edu",{"name":86,"role":49,"phone":11,"phoneExt":11,"email":11},"Andrea Bullock, MD",{"facility":88,"status":29,"city":89,"state":90,"zip":91,"country":33,"countryCode":34,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"Henry Ford Centre","Detroit","Michigan","48202",{"type":36,"coordinates":93},[94,95],-83.04575,42.33143,{"lat":95,"lon":94},[98,102],{"name":99,"role":44,"phone":100,"phoneExt":11,"email":101},"Christina Vu, Study Nurse","+1 313-556-8107","cvu1@hfhs.org",{"name":103,"role":49,"phone":11,"phoneExt":11,"email":11},"Maria Diab, MD",{"facility":105,"status":29,"city":106,"state":107,"zip":108,"country":33,"countryCode":34,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital","Philadelphia","Pennsylvania","19107",{"type":36,"coordinates":110},[111,112],-75.16362,39.95238,{"lat":112,"lon":111},[115,119,122],{"name":116,"role":44,"phone":117,"phoneExt":11,"email":118},"Babar Bashir, MD","(215) 955-4279","Babar.Bashir@jefferson.edu",{"name":120,"role":44,"phone":117,"phoneExt":11,"email":121},"Priscilla Machado -Sub Investigator, MD, FAIUM","priscilla.machado@jefferson.edu",{"name":116,"role":49,"phone":11,"phoneExt":11,"email":11},{"facility":124,"status":29,"city":125,"state":107,"zip":126,"country":33,"countryCode":34,"cosmosGeoPoint":127,"geoPoint":131,"contacts":132},"Allegheny General Hospital","Pittsburgh","15212",{"type":36,"coordinates":128},[129,130],-79.99589,40.44062,{"lat":130,"lon":129},[133,137,140],{"name":134,"role":44,"phone":135,"phoneExt":11,"email":136},"Paul Renz, DO","+1-412-359-3400","paul.renz@ahn.org",{"name":138,"role":44,"phone":11,"phoneExt":11,"email":139},"Linda Kernrick (Study Coordinator)","linda.kernick@ahn.org",{"name":134,"role":49,"phone":11,"phoneExt":11,"email":11},{"facility":142,"status":29,"city":143,"state":144,"zip":145,"country":33,"countryCode":34,"cosmosGeoPoint":146,"geoPoint":150,"contacts":151},"Brown University Cancer Institute","Providence","Rhode Island","02906",{"type":36,"coordinates":147},[148,149],-71.41283,41.82399,{"lat":149,"lon":148},[152,156,159],{"name":153,"role":44,"phone":154,"phoneExt":11,"email":155},"Alexander Raufi, MD","+1 (844) 222-2881","ARaufi2@brownhealth.org",{"name":157,"role":44,"phone":11,"phoneExt":11,"email":158},"Lindsey Cavanagh Study Nurse","lcavanagh@brownhealth.org",{"name":153,"role":49,"phone":11,"phoneExt":11,"email":11},{"facility":161,"status":29,"city":162,"state":162,"zip":163,"country":164,"countryCode":165,"cosmosGeoPoint":166,"geoPoint":170,"contacts":171},"CAMBRIDGE CANCER TRIALS CENTRE-Addenbrooke's Hospital","Cambridge","CB2 0QQ","United Kingdom","UK",{"type":36,"coordinates":167},[168,169],0.11667,52.2,{"lat":169,"lon":168},[172,176,179],{"name":173,"role":44,"phone":174,"phoneExt":11,"email":175},"Emma Wong Team Co-Lead for Aerodigestive, HPB, Head & Neck Trials Team","+44(0)1223 216083","emma.wong1@nhs.net",{"name":177,"role":44,"phone":174,"phoneExt":11,"email":178},"Joanne Mayhew Research Nurse","joanne.mayhew1@nhs.net",{"name":180,"role":49,"phone":11,"phoneExt":11,"email":11},"Kiran Purushothaman, MD",{"facility":182,"status":29,"city":183,"state":184,"zip":185,"country":164,"countryCode":165,"cosmosGeoPoint":186,"geoPoint":190,"contacts":191},"Gary Weston Centre- Imperial College Healthcare- Du Cane Road","Hammersmith","London","W12 0HS",{"type":36,"coordinates":187},[188,189],-0.22882,51.49384,{"lat":189,"lon":188},[192,196],{"name":193,"role":44,"phone":194,"phoneExt":11,"email":195},"Richard Senior Clinical Research Practitioner","+44 (0)203 313 8367","richard.elliott2@nhs.net",{"name":197,"role":49,"phone":11,"phoneExt":11,"email":11},"Harpreet Wasan, Professor: MBBS:MRCP",{"facility":199,"status":29,"city":200,"state":201,"zip":202,"country":164,"countryCode":165,"cosmosGeoPoint":203,"geoPoint":207,"contacts":208},"The Royal Marsden- Downs Road","Sutton","Surrey","SM2 5PT",{"type":36,"coordinates":204},[205,206],-0.2,51.35,{"lat":206,"lon":205},[209,213,216],{"name":210,"role":44,"phone":211,"phoneExt":11,"email":212},"Lucy Scott Senior Clinical Trial Coordinator","+44 (0)20 3186 5541","Lucy.Scott@rmh.nhs.uk",{"name":214,"role":44,"phone":211,"phoneExt":11,"email":215},"Hazel Lotte Principal Investigator","Hazel.Lote@rmh.nhs.uk",{"name":217,"role":49,"phone":11,"phoneExt":11,"email":11},"Hazel Lote, MD",{"type":219,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100581462","phase-2-acoustic-cluster-therapy-act-with-chemotherapy-for-the-treatment-of-locally-advanced-pancreatic-cancer-100581462",false,"NCT06850623","Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer","A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer","ENACT","Inclusion Criteria:\n\n* Not deemed suitable for primary curative surgery and have radiographic and pathological disease consistent with inoperable LAPC or borderline resectable pancreatic cancer.\n* Suitable to receive treatment with mFOLFIRINOX according to the Investigator's assessment.\n\nExclusion Criteria:\n\n• Any prior anti-cancer treatment for pancreatic cancer (e.g. chemotherapy, surgery, radiation). Palliative bypass procedure and bile duct stenting are allowed.","ALL","18 Years",{"count":231,"type":232},25,"ESTIMATED","INTERVENTIONAL",[235],"PHASE2","The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.",[238],"Locally Advanced Pancreatic Adenocarcinoma",[240,241,242,243,244,245,246,247,18,248],"pancreatic cancer","PS101","ultrasound","microbubbles","Pancreatic Ductal Carcinoma","locally advanced pancreatic cancer","first line treatment","chemotherapy","mFOLFIRINOX","2026-03-30",{"date":251,"type":252},"2026-04-03","ACTUAL",{"date":254,"type":252},"2025-06-19",{"date":256,"type":232},"2027-07-15",{"name":5,"class":6},10]